Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2. (Q41202102)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

review article

1 reference

title

Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

multiple endocrine neoplasia

21 October 2019

main subject

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

G J Cote

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

D B Evans

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

H Goepfert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

N G Ordonez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

R F Gagel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

Endocrinology and Metabolism Clinics of North America

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

1-25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Symptomatic C-cell Hyperplasia Associated With Chronic Lymphocytic Thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Identification of a polymorphism in exon 11 of the RET protooncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Multiple endocrine neoplasia. Type IIa.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Identification of the Cys634-->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Cytogenetic characterization of three human and three rat medullary thyroid carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Mutations of the RET proto-oncogene in Hirschsprung's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Mutation of theRET protooncogene in sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Mutation detection by denaturing gradient gel electrophoresis (DGGE).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

The impact of gene mapping techniques on the management of multiple endocrine neoplasia type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

The role of genetic screening in the management of hereditary malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Clinical use of molecular information in the management of multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Haplotype analysis of MEN 2 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

From neural crest to bowel: development of the enteric nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Inherited cancers associated with the RET proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Provocative testing for occult medullary carcinoma of the thyroid: findings in seven children with multiple endocrine neoplasia type IIa.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Cancer risks in patients with chronic lymphocytic thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Direct sequencing of PCR products in agarose gel slices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Inherited breast and ovarian cancer. What are the risks? What are the choices?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Presymptomatic testing using DNA markers for individuals at risk for familial multiple endocrine neoplasia 2A.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Hereditary nonpolyposis colorectal carcinoma (HNPCC): clinical application of molecular diagnostic testing

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

A Rapid Screening Method for the Detection of Mutations in the RET Proto-oncogene in Multiple Endocrine Neoplasia Type 2A and Familial Medullary Thyroid Carcinoma Families

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Early Diagnosis of Medullary Carcinoma of the Thyroid Gland by Means of Calcitonin Assay

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

A de novo mutation of the RET proto-oncogene in a patient with MEN 2A

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Statement on Use of DNA Testing for Presymptomatic Identification of Cancer Risk

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Hereditary localized pruritus in affected members of a kindred with multiple endocrine neoplasia type 2A (Sipple's syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Neural crest-derived cells isolated from the gut by immunoselection develop neuronal and glial phenotypes when cultured on laminin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Multiple endocrine syndrome type IIb in early childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

The occurrence of multiple endocrine neoplasia type IIb, in two children of an affected mother.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

The association of pheochromocytoma with carcinoma of the thyroid gland

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Epidemiology of medullary carcinoma of the thyroid gland: a 5-year experience (1971-1976)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Activation of a novel human transforming gene, ret, by DNA rearrangement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

One gene—four syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Medullary carcinoma arising in a thyroid with Hashimoto's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

The Early Diagnosis of Medullary Carcinoma of the Thyroid Gland in Patients with Multiple Endocrine Neoplasia Type II

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC: s

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970310-8

7 January 2021

10.1016/S0889-8529(05)70310-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8907678%20AND%20SRC:MED&resulttype=core&format=json

release_snx25sxdajdgpllht5eprtiwwi

21 October 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/snx25sxdajdgpllht5eprtiwwi

24 November 2022

mapped directly with Wikidata item

1 reference